Literature DB >> 25059285

Definitions in hemophilia: communication from the SSC of the ISTH.

V S Blanchette1, N S Key, L R Ljung, M J Manco-Johnson, H M van den Berg, A Srivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25059285     DOI： 10.1111/jth.12672

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  137 in total

1.  Combined anti-CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors.

Authors:  Bhavya S Doshi; Leslie J Raffini; Lindsey A George
Journal:  J Thromb Haemost       Date:  2020-03-02       Impact factor: 5.824

Review 2.  How I treat patients with inherited bleeding disorders who need anticoagulant therapy.

Authors:  Karlyn Martin; Nigel S Key
Journal:  Blood       Date:  2016-04-22       Impact factor: 22.113

3.  Variation of rs3754689 at lactase gene and inhibitors in admixed Brazilian patients with hemophilia A.

Authors:  Luciana W Zuccherato; Silvana M Elói-Santos; Letícia L Jardim; Ricardo M Camelo; Daniel G Chaves; Renan P Souza; Edward J Hollox; Suely M Rezende
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

4.  Vascular Permeability and Remodelling Coincide with Inflammatory and Reparative Processes after Joint Bleeding in Factor VIII-Deficient Mice.

Authors:  Esther J Cooke; Jenny Y Zhou; Tine Wyseure; Shweta Joshi; Vikas Bhat; Donald L Durden; Laurent O Mosnier; Annette von Drygalski
Journal:  Thromb Haemost       Date:  2018-05-30       Impact factor: 5.249

5.  Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study.

Authors:  Beth Boulden Warren; Dianne Thornhill; Jill Stein; Michael Fadell; J David Ingram; Sharon Funk; Kristi L Norton; Heidi D Lane; Carolyn M Bennett; Amy Dunn; Michael Recht; Amy Shapiro; Marilyn J Manco-Johnson
Journal:  Blood Adv       Date:  2020-06-09

6.  Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

Authors:  Elena Santagostino; Uri Martinowitz; Toshko Lissitchkov; Brigitte Pan-Petesch; Hideji Hanabusa; Johannes Oldenburg; Lisa Boggio; Claude Negrier; Ingrid Pabinger; Mario von Depka Prondzinski; Carmen Altisent; Giancarlo Castaman; Koji Yamamoto; Maria-Teresa Álvarez-Roman; Christine Voigt; Nicole Blackman; Iris Jacobs
Journal:  Blood       Date:  2016-01-11       Impact factor: 22.113

7.  A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.

Authors:  Kathryn G Link; Michael T Stobb; Matthew G Sorrells; Maria Bortot; Katherine Ruegg; Marilyn J Manco-Johnson; Jorge A Di Paola; Suzanne S Sindi; Aaron L Fogelson; Karin Leiderman; Keith B Neeves
Journal:  J Thromb Haemost       Date:  2019-11-01       Impact factor: 5.824

8.  Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgery.

Authors:  Ron Aa Mathôt; Marjon H Cnossen; Tim Preijers; Britta Ap Laros-vanGorkom
Journal:  BMJ Case Rep       Date:  2019-01-14

9.  The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.

Authors:  J Michael Soucie; Paul E Monahan; Roshni Kulkarni; Barbara A Konkle; Marshall A Mazepa
Journal:  Blood Adv       Date:  2018-08-28

Review 10.  Care models in the management of haemophilia: a systematic review.

Authors:  C H T Yeung; N Santesso; M Pai; C Kessler; N S Key; M Makris; T Navarro-Ruan; J M Soucie; H J Schünemann; A Iorio
Journal:  Haemophilia       Date:  2016-07       Impact factor: 4.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.